Qianting Lu
Overview
Explore the profile of Qianting Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
51
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang K, Gu C, Yu G, Lin J, Wang Z, Lu Q, et al.
Liver Res
. 2025 Feb;
6(3):167-174.
PMID: 39958198
Background And Aims: Berberine is one of the most promising clinically tested natural alkaloids, and immunotherapy using natural killer (NK) cells is a potentially effective treatment for hepatocellular carcinoma (HCC)....
2.
Yu A, Su H, Yu P, Cai S, Mu S, Yu J, et al.
Front Med (Lausanne)
. 2025 Feb;
11:1494952.
PMID: 39902031
We report an elderly male with mucin-producing urothelial-type adenocarcinoma of the prostate (MPUAP) and oligometastatic lung involvement, initially diagnosed as benign prostatic hyperplasia and treated with transurethral plasma resection of...
3.
Wang K, Lu Q, Luo Y, Yu G, Wang Z, Lin J, et al.
Biol Direct
. 2024 Jan;
19(1):4.
PMID: 38163874
Background: Aberrant expression and activation of circular RNAs (circRNAs) are closely associated with various cancers. The role of circ_MAPK9 (hsa_circ_0001566) in cancer progression remains unknown. This study aims to investigate...
4.
Wang K, Yu G, Lin J, Wang Z, Lu Q, Gu C, et al.
Front Pharmacol
. 2021 Jul;
12:632201.
PMID: 34220494
Regorafenib resistance is a key limiting factor in the treatment of advanced hepatocellular carcinoma (HCC). Increasing evidence has demonstrated that Berberine (BBR) can synergistically enhance the therapeutic effect of various...
5.
Mai W, Xu Y, Xu J, Zhao D, Ye L, Yu G, et al.
Front Pharmacol
. 2020 Mar;
11:185.
PMID: 32194416
Berberine (BBR), an isoquinoline alkaloid originating from herbal plants, has been deemed beneficial for non-alcoholic fatty liver disease. Increasing evidence has demonstrated that Nod-like receptor family pyrin domain containing 3...